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Romania
Introduction. Premalignant condition and lesions of the stomach such as intestinal metaplasia 
or atrophy are very wide-spread nowadays and it seems to be determinated by various factors.The aim 
of this study is to evaluate in which measure Helicobacter pylori correlates with premalignant lesions of 
the stomach in our area of the country.
Materials and methods.We included in the study a total of 792 patients, from whom we took 
gastric biopsies for different clinical symptoms, biopsies that have been evaluated in the Department of 
Pathology, Targu Mures County Emergency Hospital, between January and December 2015. We 
established if Helicobacter pylori infection is present, where the infection is localized at the level of 
gastric mucosa, the type of the gastric premalignant conditions and we also performed a statistical 
comparative study between the followed parameters.
Results.From a total of 792 patients, 243(30.68%) present the infection with Helicobacter pylori. 
We demonstrated that Helicobacter pylori infection is localized with predilection in the antrum of the 
stomach-154(63.4%), while only 22(9.1%) patients have infection in the body and 67(27.6%) both in 
the antrum and the body. From the patients diagnosed with Helicobacter pylori infection, 37(15.22%) of 
them present complete intestinal metaplasia, 41(16.87) incomplete intestinal metaplasia and 35(14.40%) 
atrophy.
Conclusions.Our results emphasize the fact that the number of the patients with Helicobacter 
pylori infection that were diagnosed based on biopsies is relatively reduced comparing with the total 
number of evaluated biopsies. In the cases were this infection is diagnosed, the association with 
premalignant conditions is statistically significant (p<0.0001).
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Introduction: Inflammatory bowel diseases (IBD) - ulcerative colitis (UC) and Crohn’s disease 
(CD), have chronic progression evolution with frequent extraintestinal manifestations and increasing 
incidence in East Europe, inclusive in Moldova.
The aim of the study was to investigate the frequency and spectrum of extraintestinal pathology 
Associated with IBD in Moldova – the region with very high incidence of liver and articular disorders.
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Materials and methods: The study was open prospective and included 126 patients with IBD 
(56% female, age of 18-67 years) who were treated in Republican Clinical Hospital in 2015. Diagnosis 
of ulcerative colitis or Crohn’s disease was confirmed endoscopically and histologically. The following 
methods were used to diagnose extraintestinal manifestation: clinical, ultrasonography, X-ray, 
biochemical tests, immunological markers etc.
Discussion results: 114 (90,5%) patients were diagnosed with UC, 11 (8,7%) with CD and 1 
(0,8%) with IBD type unclassified (IBDU). The most frequent extraintestinal manifestation was liver 
pathology, diagnosed in 30 (23,8%) patients. The spectrum of diseases was broad and included: chronic 
viral hepatitis B and C – 12 (9,5%), liver steatosis – 9 (7,1%), nonspecific reactive hepatitis - 5 (4,0%), 
drug induced hepatitis 2 (1,6%), primary sclerosing cholangitis – 1 (0,8%) and primary biliary cirrhosis
1 (0,8%). 
Arthropathy was diagnosed in 18 (14,3%) patients. Peripheral arthropathy was more frequent 
than central arthropathy: peritheral oligoartritis – 5 (4,0%), poliartritis 7 (5,6%) in comparison with 
sacroiliitis – 5 (4,0%) and ankylosing spondylitis – 1 (0,8%). Skin and mucosal affectations were 
observed in 6 (4,8%) patients: aphthous stomatitis – 3 (2,4%), pyoderma gangrenosum – 1 (0,8%), 
nodular erythema – 1 (0,8%), and Sweet syndrome – 1 (0,8%). Ocular affectation was diagnosed in 4 
(3,2%) cases. Extraintestinal manifestations were more frequent in association than as mono 
extraintestinal disorder – 22 (17,5%) and 12 (9,5%) patients respectively, and the common associations 
were liver-articular, skin-articular. It was not revealed significant interrelation between activity/ 
extention/localization of IBD and severity of extraintestinal manifestation. Exception have made 
nonspecific reactive hepatitis, peritheral oligoartritis, and pyoderma gangrenosum which was 
characteristic for a severe debut of IBD.
Conclusion: An essential number of IBD patients have Associated extraintestinal pathology 
(27%). Liver diseases were diagnosed more often and skin and ocular lesions less frequent in comparison 
with literature data.
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Introduction: Urinary tract infections (UTIs) are among the most common infectious diseases 
occurring in either the community or healthcare setting.1 Uncomplicated UTIs typically occur in the 
healthy adult non-pregnant woman, while complicated UTIs (cUTIs) may occur in all sexes and age 
groups and are frequently Associated with either structural or functional urinary tract abnormalities. 
Examples include foreign bodies such as calculi indwelling catheters or other drainage devices, 
obstruction, immunosuppression, renal failure, renal transplantation and pregnancy
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